Section Editors

Aksel Siva - MD, FEAN, Professor of Neurology, Clinical Neuro-immunology Unit and MS Clinic, Department of Neurology, Istanbul University, Cerrahpaşa School of Medicine

Aksel Siva

MD, FEAN, Professor of Neurology, Clinical Neuro-immunology Unit and MS Clinic, Department of Neurology, Istanbul University, Cerrahpaşa School of Medicine

Aksel Siva currently works as Professor of Neurology, at the Department of Neurology of Istanbul University, Cerrahpaşa School of Medicine where he was the past-chairman, and continues to head the Clinical Neuro-immunology Unit & Multiple Sclerosis Clinic, and acts as senior advisor of the Headache Clinic.
He served as President of the Turkish Neurological Society (TNS) for three consecutive terms 2003–2009, and is the chair of its scientific committee. He is a founding member of the Turkish Multiple Sclerosis Society and the MS Chapter of the TNS. He has served as an executive committee member of the European Neurological Society (ENS) 2009–2014 and currently is a member of the EAN scientific programme committee (2014–2018). He served on the Education Committee of the World Federation of Neurology (WFN) and currently is the chair of the WFN Standards & Evaluations Committee. He is a member of the European Academy of Neurology, American Academy of Neurology, American Neurological Association and European Headache Federation.
His areas of research interest and work are: clinical neuro-immunology, mainly multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), radiologically isolated syndrome (RIS) and neuro-Behçet’s syndrome. He is also involved in clinical work in headaches and neuro-epidemiology. He has authored over 100 peer-reviewed articles and has written many book chapters, and gives lectures as an invited speaker at national and international meetings and institutions.

Cris S Constantinescu - Professor, Division of Clinical Neurology, University of Nottingham, Queen's Medical Centre

Cris S Constantinescu

Professor, Division of Clinical Neurology, University of Nottingham, Queen's Medical Centre

Dr Constantinescu’s interests include neuroimmunology, multiple sclerosis, experimental models of demyelinating disease, immunologic tolerance, cytokines and neuroimaging.
He has authored over 100 peer reviewed articles and is an invited speaker at national and international institutions. Former recipient of Physician Scientist Award from the NIH Research Grants and Awards American Neurological Association.
Society affiliations, including Association of British Neurologists American Academy of Neurology British Society of Immunology American Academy of Neurology European Neuro-Ophthalmology Society (EUNOS) American Association of Immunologists Society for Leukocyte Biology British Medical Association American Neurological Association International Society of Neuroimmunology.

View Press Release - Prof. Constantinescu becomesEuropean Neurological Review Editor-in-Chief here.

Francois Bethoux, MD - Director, Rehabilitation Services, Mellen Center for Multiple Sclerosis, The Cleveland Clinic

Francois Bethoux, MD

Director, Rehabilitation Services, Mellen Center for Multiple Sclerosis, The Cleveland Clinic

Dr. Bethoux is a principal or co-investigator in a number of research studies in the area of multiple sclerosis rehabilitation, ambulation, and spasticity management. Dr. Bethoux has spoken both nationally and internationally on these topics. Dr. Bethoux's work has been published in many peer-reviewed medical journals. Dr Bethoux also authored several book chapters and co-edited a book on outcome measures for rehabilitation.

Dr. Bethoux has contributed to several expert panels. He currently chairs the Research Interest Group on symptom management of the Consortium of Multiple Sclerosis Centers. He is a member of the American Academy of Neurology and of the International Society for Quality of Life Research.

Latest Articles

Latest Videos

Video List based on Category on Node Page

Latest Videos

EAN Programme Committee Member, Prof. Aksel Siva, considers current unmet needs in the treatment of multiple sclerosis and shares his hopes for the future. Part 2 of 2. View Part 1 here. Speaker disclosures: Prof. Aksel Siva has received honoraria for giving educational presentations at several national or international congresses or symposia and consultation fees from Novartis, Genzyme...
Dr Patrick Vermersch discusses teriflunomide’s role in the treatment of multiple sclerosis, the focus of his article recently published in European Neurological Review. View his article here. Speaker disclosures: Consultant and/or support for research from: Novartis, Biogen, Sanofi, Teva, Servier, Roche and Celgene. Filmed at the 3rd Congress of the European Academy of Neurology...
We catch up with Prof. Cris Constantinescu to discuss this year’s AAN coverage on multiple sclerosis, and he reveals which presentation he found the most interesting while here. Speaker disclosures: TBC Filmed at the American Academy of Neurology (AAN) Annual Meeting, Boston, US, April 2017

Multiple Sclerosis INSIGHTS

The touchNEUROLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of neurology:

Insight
No evident disease activity (NEDA) may become the new standard for disease control in multiple sclerosis

Catherine Amey, Senior Medical Writer, Touch Medical Media, Goring-On-Thames, Reading, UK

Insight
B-cell proliferation following alemtuzumab treatment may create new autoimmunities in patients with multiple sclerosis

Catherine Amey, Senior Medical Writer, Touch Medical Media, Reading, UK

Lay Summary
Relationship between vitamin D and interferon beta-1b in the treatment of multiple sclerosis

Catherine Amey, Senior Medical Writer, Touch Medical Media, Reading, UK

Lay Summary
Vitamin D deficiency in multiple sclerosis

Catherine Amey, Senior Medical Writer, Touch Medical Media, Reading, UK